CNBC's Eamon Javers joins 'The Exchange' to report the latest on the FTC's lawsuit against drug middlemen for allegedly ...

As the leader of Connecticut’s #insulin4all chapter, I’ve met countless patients who have struggled to afford their insulin.

Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes ...

As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Insulet (PODD – Research Report) today and set a price target of ...

Dividend stocks can be a great way to boost your portfolio's returns by generating extra income apart from just stock price ...

Despite the current downward trend of Novo Nordisk, it is an excellent stock to buy for long-term gains, driven by the ...

Lexicon Pharmaceuticals (LXRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

Your pancreas makes insulin and releases C-peptide when you ... Include medicines you take by prescription and those you buy over the counter, such as herbal supplements or vitamins.

Vice President Kamala Harris has proposed a cap on the cost of insulin at $35 and more price ... [+] controls on prescription drugs through Medicare. Vice President Kamala Harris has caught flak ...